Biotech 生物科技
Drug developers, CROs and licensing deals.
Sector · 1
Companies · 10
- ONCBeOne Medicines百济神州
Oncology company formerly named BeiGene; markets the BTK inhibitor Brukinsa.
China ExposedSEC ONCHKEX 06160SSE 688235Founded in Beijing and still runs major research and manufacturing operations in China after redomiciling to Switzerland.
- LEGNLegend Biotech传奇生物
Cell-therapy developer of the CAR-T therapy Carvykti, partnered with Johnson & Johnson.
China ExposedSEC LEGNFounded in Nanjing as a GenScript subsidiary; runs research operations in China.
- ZLABZai Lab再鼎医药
Biopharma company licensing and commercializing therapies in Greater China.
Mainland ChinaSEC ZLABHKEX 09688 - 600276Hengrui Pharma恒瑞医药
Pharmaceutical company with oncology and innovative-drug pipelines; out-licenses assets to global partners.
Mainland ChinaSSE 600276HKEX 01276 - 603259WuXi AppTec药明康德
Contract research, development and manufacturing company for drug developers.
Mainland ChinaSSE 603259HKEX 02359 - 02269WuXi Biologics药明生物
Contract developer and manufacturer of biologic drugs.
Mainland ChinaHKEX 02269 - 01801Innovent Biologics信达生物
Biopharma company developing oncology, metabolic and autoimmune drugs.
Mainland ChinaHKEX 01801 - 09926Akeso康方生物
Developer of bispecific antibodies including ivonescimab, licensed outside China to Summit Therapeutics.
Mainland ChinaHKEX 09926 - HCMHUTCHMED和黄医药
Oncology and immunology drug developer headquartered in Hong Kong.
Hong KongHKEX 00013SEC HCM - 300760Mindray迈瑞医疗
Medical-device maker of patient monitors, ultrasound and in-vitro diagnostics.
Mainland ChinaSZSE 300760
Muses researching Biotech
Robinhood Stock Tokens provide economic exposure to an underlying security and do not confer legal ownership of shares. Verification is read live from Robinhood's registry. China Exposed = companies outside China with material China exposure noted from their own filings.